Evidence Library
452 graded sources. Click an ID to view the full context summary and source link.
What do Grade and Tier mean?
Show internal research links
| ID | Summary | Grade | Tier / retrieved |
|---|---|---|---|
ID | Summary | Grade | Tier / retrieved |
BIB_001 | Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer | A | Tier 1Retrieved May 6, 2026 |
BIB_002 | Lo SN, Scolyer RA, Thompson JF. Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas: A Breslow Thickness Cut Point of 0.8 mm Separates Higher-Risk | A | Tier 2Retrieved May 6, 2026 |
BIB_003 | Egger ME, Stevenson M, Bhutiani N, Jordan AC, et al. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8th Edition? J Am Coll Surg | B | Tier 2Retrieved May 6, 2026 |
BIB_004 | Isaksson K, Mikiver R, Eriksson H, Lapins J, et al. Survival in 31,670 patients with thin melanomas: a Swedish population-based study. Br J Dermatol 2021;184(5) | A | Tier 2Retrieved May 6, 2026 |
BIB_005 | Vecchiato A, Cozzolino C, Del Fiore P, et al. Identifying high-risk features and improving follow-up strategies in thin melanoma: a retrospective cohort study. | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_006 | Savage DJ, Switzer B, Parikh R, et al. Patterns in progression from early-stage melanoma to late-stage melanoma: implications for survivorship follow-up. Melano | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_007 | Richetta AG, Bottoni U, Paolino G, et al. Thin melanoma and late recurrences: it is never too thin and never too late. Med Oncol 2014;31(8):909. PMID 24610543. | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_008 | Pescarini E, Spanikova G, Mbaidjol Z, et al. Late Metastatic Melanoma after 25 Years: A Case Report and a Brief Literature Review. Case Rep Surg 2020. PMID 3317 | C | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_009 | Thompson JF, Soong SJ, Balch CM, Gershenwald JE, et al. Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients | A | Tier 2Retrieved May 6, 2026 |
BIB_010 | Azimi F, Scolyer RA, Rumcheva P, Moncrieff M, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival | A | Tier 2Retrieved May 6, 2026 |
BIB_011 | Sabbatino F, Scognamiglio G, Liguori L, et al. Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma. Front Immunol 2020. PMID 33117345. | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_012 | Fidanzi C, Bevilacqua M, D'Erme AM, et al. Mitotic rate as a predictive factor for positive sentinel lymph nodes in pT1 and pT2 melanomas. J Plast Reconstr Aest | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_013 | Mayhew MM, Tocco EG, Mercante MG, et al. Patterns and Predictors of Sentinel Lymph Node Biopsy Utilization in High- and Low-Risk Thin Melanomas. Ann Surg Oncol | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_014 | Donica WRF, Stephens KR, Philips P, et al. Predictors of SLNB in Thin Melanoma: Understanding the Impact of the AJCC 8th Edition Staging System. J Am Coll Surg | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_015 | Marushchak O, Hazan E, Kriegel DA. Analyzing Controversies in Management and Surveillance of Early-Stage Melanoma. Oncol Ther 2020. PMID 32930972. | C | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_016 | Gambra Michel LE, Uña Gorospe J, López Figueroa AL, et al. Disease-Free Survival for Patients with Thin Melanomas according to the AJCC 8th Edition. Dermatology | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_017 | Vergara-de la Campa L et al. Prognosis of polypoid melanoma. Melanoma Res 2023. PMID 36866632. | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_018 | Yu et al. A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors. Front Immunol 2023. PMID 38053661. | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_019 | Sentinel-node positivity in very thin (<0.8 mm) melanoma. Br J Dermatol 2023. PMID 37290803. DOI 10.1093/bjd/ljad195. | B | Tier 3Re-review dueRetrieved May 6, 2026 |
BIB_020 | Risk factors and patterns of recurrence after SLNB for thin melanoma. 2022. PMID 33884478. | B | Tier 3Re-review dueRetrieved May 6, 2026 |